Month: July 2026

2026.07.02
Another patent granted. Another step in building global protection for Genomtec’s molecular diagnostics technology

2026.06.03
Genomtec Secures Over EUR 9 Million to Advance Commercialization Strategy and AI-Powered Diagnostics Development

2026.05.19
Launch of the public offering of Genomtec shares to raise funds for the finalization of the M&A process and the commercialization of Genomtec ID and OncoSNAAT® technologies

2026.03.19
Genomtec plans to issue shares. The proceeds will be used to support the M&A process and commercialize projects. The company has concluded an investment agreement with a key shareholder.

2026.02.12
Genomtec lines up technology trials with potential Asian partners during M&A efforts

Archive

2026.07.02

Another patent granted. Another step in building global protection for Genomtec’s molecular diagnostics technology

We are pleased to share that Genomtec has received a decision from the United States Patent and Trademark Office (USPTO) granting a patent for ...
Read

Archive